HeMo Wald ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  18.1% 11.1% 17.0% 14.9% 10.6%  
Credit score (0-100)  9 23 10 13 22  
Credit rating  B B B B B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Gross profit  -12.7 0.7 -0.7 -5.1 1.0  
EBITDA  -12.7 0.7 -0.7 -5.1 1.0  
EBIT  -12.7 0.7 -0.7 -5.1 1.0  
Pre-tax profit (PTP)  -12.7 0.7 -0.8 -5.2 1.0  
Net earnings  -17.9 0.7 -0.8 -5.2 1.0  
Pre-tax profit without non-rec. items  -12.8 0.7 -0.8 -5.2 1.0  

 
See the entire income statement

Balance sheet (kDKK) 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  13.7 14.4 13.7 8.5 9.5  
Interest-bearing liabilities  2.6 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  18.7 20.5 19.4 18.5 15.0  

Net Debt  -14.5 -14.5 -19.4 -17.2 -8.7  
 
See the entire balance sheet

Volume 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -12.7 0.7 -0.7 -5.1 1.0  
Gross profit growth  45.9% 0.0% 0.0% -627.4% 0.0%  
Employees  1 1 0 1 1  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  19 21 19 19 15  
Balance sheet change%  -52.7% 9.5% -5.4% -4.6% -19.2%  
Added value  -12.7 0.7 -0.7 -5.1 1.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 -1.0 -2.0 1.0  

Profitability 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -43.6% 3.5% -3.5% -27.0% 6.1%  
ROI %  -50.3% 4.5% -5.0% -46.2% 11.2%  
ROE %  -78.9% 4.9% -5.4% -46.5% 11.0%  

Solidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12
Equity ratio %  73.3% 70.3% 70.4% 46.0% 63.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  114.3% -2,111.8% 2,753.0% 336.1% -859.8%  
Gearing %  18.8% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  2.1% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12
Quick Ratio  3.7 3.4 3.4 1.9 2.7  
Current Ratio  3.7 3.4 3.4 1.9 2.7  
Cash and cash equivalent  17.1 14.5 19.4 17.2 8.7  

Capital use efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  13.7 14.4 13.7 8.5 9.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2018
2019/6
2019
2020/6
2020
2021/6
2021
2021/12
2022
2022/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -13 1 0 -5 1  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -13 1 0 -5 1  
EBIT / employee  -13 1 0 -5 1  
Net earnings / employee  -18 1 0 -5 1